1. PCORI Meeting Materials: Latino Roundtable, click here to view the meeting agenda, and here to view the presentation slides.
2. PCORI Blog: Digging Deeper into PCORI's Cycle II Awards, click here to view the blog post.
3. PCORI to Host Roundtable, Webinar on Data Dissemination, click here to register for the webinar, and here to submit questions and responses.
4. PIPC Chairman Comments on Living with a Disability, Patient Centered CER, click hereto view the blog post.
5. It's Time for Insurers to Pony Up PCORI Fees, click here to view the article (subscription only).
6. Pink Sheet: Woodcock Pushes Standardization to Speed Rx Development, But Will Uniformity Cripple Innovation?, click here to view the article (subscription only).
On Tuesday, July 23 the Patient Centered Outcomes Research Institute (PCORI) held a Latino Roundtable Discussion. The purpose of the roundtable was for PCORI to leverage the wisdom and experience of Latino patients, healthcare professionals, and the organizations that represent them to help guide development of an innovative and patient-centered research agenda to improve healthcare delivery and patient outcomes. Their objectives included: (1) create community and promote interest in patient-centered research among Latino male patients and health professionals; (2) identify healthcare issues and outcomes important to Latino men for future research; (3) identify barriers and gaps in knowledge or opportunities for dissemination and implementation; (4) gain input from Latino men on PCORI’s research programs; and (5) identify how PCORI should engage Latino men in our research process. Click here to view the meeting agenda, and here to view the presentation slides.
2. PCORI Blog: Digging Deeper into PCORI's Cycle II Awards
In a recent post on the PCORI Blog, PCORI Executive Director Joe Selby writes, “I'm pleased to share the latest analysis of our most recent awards cycle, including the volume of applications received, types of research proposed, and other attributes of the projects we have added to our growing portfolio. Compared to our first funding cycle, we were able to fund a much higher percentage of the proposals we received. The funding rate in Cycle II was 12 percent, compared with 5 percent in Cycle I. This increase, in large part, reflects a greater understanding of our unique patient-centered requirements.” Click here to view the blog post.
3. PCORI to Host Roundtable, Webinar on Data Dissemination
PCORI will hold a roundtable on July 29, 2013 to discuss the dissemination and implementation of comparative clinical effectiveness research (CER) findings. According to a release from PCORI, “We are commissioning the development of the PCORI Blueprint for Dissemination and Implementation of Research to complement the work with the Agency for Healthcare Research and Quality (AHRQ). The roundtable is an opportunity to provide input into the development of the request for proposal (RFP) for the commission.” You can enrich the discussion in advance by offering your responses to key questions we'll explore during the event. You can also participate in a public comment period from 4:15 p.m. to 4:45 p.m. ET by emailing your thoughts email@example.com, or by joining the Twitter conversation using #PCORI. Click here to register for the webinar, and here to submit questions and responses.
4. PIPC Chairman Comments on Living with a Disability, Patient Centered CER
In the inaugural post on the Partnership to Improve Patient Care’s (PIPC’s) Chairman’s Corner blog, PIPC Chairman Tony Coelho discusses the challenges of living with a disability, and the importance of bringing patient’s perspectives to the application of comparative effectiveness research. “Back when I was in the Congress, authoring the Americans with Disabilities Act embodied the battle that I fought for people with disabilities,” Chairman Coelho comments. “Today, the new battle is in the emerging field of comparative clinical effectiveness research. We must ensure that this research considers the unique health challenges facing not only people with disabilities, but also the elderly and those in under-served communities.”
Chairman Coelho continues to write, “As someone with epilepsy as well as a former policymaker, I know the importance of securing a seat at the table so our voice will be heard. We must urge entities like PCORI to include all people – the disabled, people of color, women and the elderly, among others – when designing new comparative clinical effectiveness research studies… As Chair of PIPC, I urge all of our members and friends to stay engaged with PCORI to ensure that their work truly improves the lives of patients.” Click here to view the blog post.
5. It's Time for Insurers to Pony Up PCORI Fees
In an article published in CQ HealthBeat, John Reichard reports, “The first insurance industry payments for a provision of the health overhaul that its framers hope will help bend the cost curve in health spending are due to the Internal Revenue Service on July 31. The money goes into the trust fund established for the Patient Centered Outcomes Research Institute. Under the health law, there are two funding streams for that account, which is expected to receive $3.5 billion through Sept. 30, 2019, when the authorization for the trust fund expires. According to the PCORI website, in fiscal 2013 the amount going into its trust fund will total $320 million, of which $150 million comes from the Treasury and the remainder from Medicare and insurers. If the research works out the way policymakers hope, the findings will identify areas of wasteful treatment that insurers will be able to avoid covering. Medicare coverage isn't automatically changed as a result of the findings, but PCORI critics claim it will lead to government rationing, while supporters say it makes no sense to spend limited health care dollars on treatment approaches that don't work.” Click here to view the article (subscription only).
6. Pink Sheet: Woodcock Pushes Standardization to Speed Rx Development, But Will Uniformity Cripple Innovation?
According to an article in this week’s The Pink Sheet, “The ultimate goal may be to use an established clinical trial and data infrastructure – such as the Patient-Centered Outcomes Research Institute's planned clinical data research networks and patient-powered research networks – to work ‘seamlessly’ in both observational and experimental research, Bryan Luce, PCORI chief science officer said. ’Imagine a new world,’ Luce said, where ‘as you do an observational study and have a hypothesis that needs to be tested you could break into clinical trials.’ He acknowledged that this will be challenging and is likely a long ways off.” Click here to view the article (subscription only).